ZGN Q4 2025 Earnings EPS Beat Drives Stock Higher Despite Revenue Disclosures Lacking NNOX Q4 2025 Earnings WiderThanExpected Loss as Revenue Details Remain Scarce PSTV Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue FLWS Q1 2026 Earnings Wide EPS Miss Despite Flattish Revenue Environment VLRS Q1 2026 Earnings EPS Beats Expectations but Stock Slips on Revenue Uncertainty